Long-Read RNA Sequencing Kits for CARD iNDI Brain Sample Study

Location: Maryland
Posted: Jun 11, 2026
Due: Jun 23, 2026
Agency: HEALTH AND HUMAN SERVICES, DEPARTMENT OF
Type of Government: Federal
Category:
  • 65 - Medical, Dental, and Veterinary Equipment and Supplies
Solicitation No: NIH-NOI-26-PCA-NIA-01599
Publication URL: To access bid details, please log in.
Follow
Long-Read RNA Sequencing Kits for CARD iNDI Brain Sample Study
Active
Contract Opportunity
Notice ID
NIH-NOI-26-PCA-NIA-01599
Related Notice
Department/Ind. Agency
HEALTH AND HUMAN SERVICES, DEPARTMENT OF
Sub-tier
NATIONAL INSTITUTES OF HEALTH
Office
NATIONAL INSTITUTES OF HEALTH OLAO
General Information
  • Contract Opportunity Type: Special Notice (Original)
  • Original Published Date: Jun 11, 2026 10:58 am EDT
  • Original Response Date: Jun 23, 2026 11:00 am EDT
  • Inactive Policy: 15 days after response date
  • Original Inactive Date: Jul 08, 2026
  • Initiative:
    • None
Classification
  • Original Set Aside:
  • Product Service Code: 6550 - IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS
  • NAICS Code:
    • 334516 - Analytical Laboratory Instrument Manufacturing
  • Place of Performance:
    Bethesda , MD 20892
    USA
Description

Notice of Intent to Sole Source / Brand Name



Notice ID: NIH-NOI-26-PCA-NIA-01599

Department/Ind. Agency: HEALTH AND HUMAN SERVICES, DEPARTMENT OF

Sub-tier: NATIONAL INSTITUTES OF HEALTH

Office: NATIONAL INSTITUTE ON AGING



Active Contract Opportunity



Notice Type



Special Notice



Original Published Date



06/11/2026



Response Date



06/23/2026, 11:00 am EST



Classification Code



6550 – In Vitro Diagnostic Substances, Reagents, Test Kits and Sets



NAICS Code



334516 – Analytical Laboratory Instrument Manufacturing



Place of Performance



National Institute on Aging

Bethesda, MD



Description



This is a Notice of Intent to Sole Source / Brand Name notice and is not a request for competitive quotations.



The National Institutes of Health (NIH), National Institute on Aging (NIA), Center for Alzheimer’s Disease and Related Dementias (CARD), intends to negotiate and award a firm-fixed-price purchase order on a sole source basis to:



Oxford Nanopore Technologies, Inc.

101 AVENUE OF THE AMERICAS, FL 7, NEW YORK, NY 10013 USA



for the purchase of brand-name Oxford Nanopore long-read RNA sequencing consumables required to support CARD’s induced Pluripotent Stem Cell Neurodegenerative Disease Initiative (iNDI).



The Government requires the following brand-name items:




  • Oxford Nanopore PromethION Flow Cells Packs DNA, Catalog No. FLO-PRO114M, Quantity 171

  • Oxford Nanopore cDNA-PCR Sequencing Kit V14, Catalog No. SQK-PCS114, Quantity 114



These consumables are required for large-scale long-read RNA sequencing of 600 postmortem human brain samples to characterize gene expression and isoform diversity in the aging and neurodegenerating brain. The resulting data will support research relevant to Alzheimer’s disease, Parkinson’s disease, and the molecular biology of brain aging.



The required supplies must meet the following salient characteristics:



Flow Cells




  • Must be able to generate consensus data at a modal accuracy above 99%

  • Must be compatible with Government-owned Oxford Nanopore PromethION 48 sequencers in form, fit, and function



cDNA-PCR Sequencing Kit




  • Must provide cDNA-PCR Sequencing Kit to prepare cDNA for nanopore sequencing

  • Must require no more than 10 ng poly(A)+ RNA or 500 ng total RNA as starting material

  • Must provide for 6 reactions



The Government’s minimum need is for brand-name Oxford Nanopore consumables because the National Institute on Aging currently operates Government-owned Oxford Nanopore PromethION 48 sequencers, and the required consumables must be fully compatible with that installed platform. The identified Oxford Nanopore flow cells and sequencing kits are proprietary products specifically designed for use with the PromethION 48 system. Other manufacturers’ sequencing consumables are designed for their own proprietary instruments and are not interchangeable with the Government’s existing Oxford Nanopore equipment.



The statutory authority for this acquisition is 41 U.S.C. 3304(a)(1), as implemented by FAR 6.302-1, Only One Responsible Source and No Other Supplies or Services Will Satisfy Agency Requirements, and pursuant to FAR 13.501(a).



This notice is not a formal solicitation. However, any responsible source that believes it can provide the required brand-name Oxford Nanopore products or can otherwise meet the Government’s requirement without compromising compatibility with the existing PromethION 48 platform, may submit a capability statement for consideration.



Interested parties must submit clear and convincing documentation demonstrating their capability to provide the exact required items or an authorized source for those items. Responses must include, at a minimum:




  1. Company name, SAM UEI, and business size status

  2. Point of contact information

  3. Evidence of ability to provide the exact brand-name items identified above, including manufacturer authorization if applicable

  4. Technical documentation demonstrating compatibility with the Government-owned Oxford Nanopore PromethION 48 sequencers

  5. Delivery capability and estimated lead time



Responses must be received by the closing date and time of this notice and shall be submitted electronically to:



Contracting Officer: Linda Smith

Email: linda.smith2@nih.gov



All responses received by the due date will be reviewed solely for the purpose of determining whether to conduct a competitive procurement or proceed with the intended sole source award. A determination by the Government not to compete this proposed action based upon responses to this notice is solely within the discretion of the Government.



No solicitation package is available.



Attachments/Links



None



Contact Information



Primary Point of Contact:



Linda Smith, Contracting Officer, linda.smith2@nih.gov



Secondary Point of Contact:



Danielle Tines (c), Procurement Technician, danielle.tines@nih.gov


Attachments/Links
Contact Information
Contracting Office Address
  • 6011 EXECUTIVE BLVD., SUITE 503L
  • BETHESDA , MD 20892
  • USA
Primary Point of Contact
Secondary Point of Contact
History
  • Jun 11, 2026 10:58 am EDTSpecial Notice (Original)
Daily notification on new contract opportunities

With GovernmentContracts, you can:

  • Find more opportunities and win more business
  • Receive daily alerts for all new bid opportunities
  • Get contract opportunities matched to your business
ONE WEEK FREE TRIAL

See also

...Partners for Clinical Research Collaborations on Therapeutics, Diagnostics or Devices for Childhood...- OTHER ...

HEALTH AND HUMAN SERVICES, DEPARTMENT OF

Bid Due: 5/31/2029

...composition (BMC, FAT, LEAN) of subjects for ongoing biomedical research studies of human ...

HEALTH AND HUMAN SERVICES, DEPARTMENT OF

Bid Due: 7/25/2026

...magnetic resonance imaging studies, radiology reports, and related clinical data necessary for research... ...

HEALTH AND HUMAN SERVICES, DEPARTMENT OF

Bid Due: 7/23/2026

...cell counter to support ongoing clinical research studies involving immune cells obtained from... ...

HEALTH AND HUMAN SERVICES, DEPARTMENT OF

Bid Due: 7/21/2026

* Disclaimer: Information regarding bids, requests for proposals (RFPs), or requests for qualifications (RFQs) is provided on this website only for convenience and does not constitute official public notice. Persons wishing to respond to or inquire about bids, RFPs, or RFQs should contact the appropriate government department.